drugset / Trial / NCT07072572

Lung Point of Care Ultrasound to Guide Albumin Administration in Cirrhosis

NCT07072572

Phase 3 Completed 72 enrolled Centro Medico Issemym
RandomizedParallel-groupOpen-labelTreatment

Summary

To guide the administration of intravenous albumin by lung ultrasound in decompensated cirrhosis.

Timeline

Start
2023-03-01
Primary completion
2023-12-14
Completion
2024-11-14

Drugs

EvaluationDrugModalityDoseRoute
Subject Albumin Protein / enzyme biologic 35 g Intravenous